Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 433M | 758M | 678M | 638M |
Cost of revenue | 99M | 326M | 288M | 254M |
Gross profit | 334M | 432M | 390M | 384M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 77M | 76M | 95M | 67M |
Other operating expenses | 98M | 98M | 131M | 75M |
Operating income | -3M | 100M | 12M | 99M |
Non operating interest income | ||||
Income | 11M | 11M | 16M | 7M |
Expense | 68M | 69M | 68M | 65M |
Other income expense | -29M | 16M | -1M | -26M |
Pretax income | -95M | 49M | -51M | 9M |
Tax provision | 11M | 7M | -8M | 31M |
Net income | -106M | 42M | -43M | -22M |
Basic EPS | -0.4 | 0.2 | — | -0.1 |
Diluted EPS | -0.4 | 0.2 | — | -0.1 |
Basic average shares | 297M | 298M | — | 296M |
Diluted average shares | 297M | 298M | — | 296M |
EBITDA | 153M | 250M | 163M | 232M |
Net income from continuing op. | -106M | 42M | -43M | -22M |
Minority interests | 7M | 4M | 4M | -1M |
Preferred stock dividends | — | — | — | — |